Einloggen
Einloggen
Oder einloggen mit
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Registrieren
Oder einloggen mit
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Startseite
  2. Aktien
  3. Deutschland
  4. Xetra
  5. MorphoSys AG
  6. News
  7. Andere Sprachen
    MOR   DE0006632003   663200

MORPHOSYS AG

(MOR)
  Bericht
Verzögert Xetra  -  17:35 05.10.2022
20.59 EUR   -2.23%
05.10.Dpa-AFX-Überblick: UNTERNEHMEN vom 05.10.2022 - 15.15 Uhr
DP
05.10.Morphosys-Vorstand: 'Großes Ziel' bleibt die Profitabilität im Jahr 2026
DP
04.10.Europäische ADRs klettern im Dienstagshandel
MT
ÜbersichtKurseChartsNewsRatingsTermineUnternehmenFinanzenAnalystenschätzungenRevisionenDerivateFonds 
ÜbersichtAlle NewsAnalystenempfehlungenAndere SprachenPressemitteilungenOffizielle PublikationenBranchen-NewsMarketScreener Analysen
Nachrichten in anderen Sprachen über MORPHOSYS AG
04.10.European ADRs Climb in Tuesday Trading
30.09.European ADRs Move Higher in Friday Trading
29.09.Sector Update: Health Care Stocks Sliding Thursday
29.09.Sector Update: Health Care Stocks Retreating on Thursday
29.09.MorphoSys Presents New Long-Term Data from L-MIND Suggesting Durable Response to Treatm..
29.09.MorphoSys Presents New Long-Term Data from L-MIND Suggesting Durable Response to Treatm..
28.09.MorphoSys Says Monjuvi Immunotherapy Shows Long-Term Efficacy in Lymphoma Patients; Sha..
28.09.MorphoSys Presents New Long-Term Data from L-MIND Suggesting Durable Response to Treatm..
28.09.European ADRs Move Higher in Wednesday Trading
28.09.Vivoryon uitblinker
27.09.European ADRs Climb Higher in Tuesday Trading
19.09.European ADRs Move Lower in Monday Trading
14.09.European ADRs Move Slightly Higher in Wednesday Trading
13.09.Transcript : MorphoSys AG Presents at Morgan Stanley 20th Annual Global Healt..
12.09.European ADRs Climb Sharply Higher in Monday Trading
12.09.Lonza nomme un nouveau directeur pour la division Cellule et Gène
09.09.European ADRs Rise Sharply in Friday Trading
09.09.InnoCare Announces First Patient Dosed in Phase II Registrational Trial of Tafasitamab ..
06.09.European ADRs Move Higher in Tuesday Trading
01.09.MorphoSys appoints Tim Demuth as new Chief Research and Development Officer, following ..
31.08.MorphoSys appoints Tim Demuth as new Chief Research and Development Officer, following ..
31.08.MorphoSys AG Announces Executive Changes
30.08.European ADRs Move Lower in Tuesday Trading
24.08.European ADRs Move Lower in Wednesday Trading
18.08.European ADRs Move Lower in Thursday Trading
15.08.European ADRs Move Sharply Lower in Monday Trading
10.08.European ADRs Climb Higher in Wednesday Trading
09.08.European ADRs Move Higher in Tuesday Trading
04.08.Morphosys : Reports Second Quarter and First Half 2022 Financial Results - Form 6-K
04.08.Transcript : MorphoSys AG, H1 2022 Earnings Call, Aug 04, 2022
03.08.MorphoSys AG Reports Second Quarter and First Half 2022 Financial Results
03.08.MorphoSys AG Reports Second Quarter and First Half 2022 Financial Results
03.08.MorphoSys AG Reports Earnings Results for the Second Quarter and Six Months Ended June ..
29.07.Morphosys : Invitation to MorphoSys' Second Quarter and First Half Year 2022 Results Confe..
28.07.Morphosys Ag : Invitation to MorphoSys' Second Quarter and First Half Year 2022 Results Co..
28.07.European ADRs Decline in Thursday Trading
27.07.MorphoSys AG Reports Preliminary Q2 2022 Monjuvi U.S. Sales and Updates Financial Guida..
27.07.MorphoSys Reports Preliminary Q2 2022 Monjuvi U.S. Sales and Updates Financial Guidance..
26.07.Ad Hoc : MorphoSys AG Reports Preliminary Q2 2022 Monjuvi U.S. Sales and Updates Financial..
26.07.MorphoSys Reports Preliminary Q2 2022 Monjuvi U.S. Sales and Updates Financial Guidance..
26.07.Morphosys Ag Updates Monjuvi U.S. Net Product Sales Guidance for the Year 2022
26.07.Ad Hoc : MorphoSys AG Reports Preliminary Q2 2022 Monjuvi U.S. Sales and Updates Financial..
19.07.European ADRs Rise in Tuesday Trading
16.07.Certain Ordinary Shares of MorphoSys AG are subject to a Lock-Up Agreement Ending on 16..
12.07.European ADRs Move Lower in Tuesday Trading
08.07.European ADRs Move Slightly Higher in Friday Trading
06.07.European ADRs Move Lower in Wednesday Trading
01.07.European ADRs Fall Sharply in Friday Trading
29.06.European ADRs Move Slightly Higher in Wednesday Trading
23.06.Morphosys Group : First Quarter Interim Statement January – March 2022 - Form 6-K
23.06.MorphoSys AG Confirms Financial Guidance for the Year 2022
21.06.European ADRs Rise Sharply in Tuesday Trading
17.06.European ADRs Move Lower in Friday Trading
15.06.I-Mab Says Partner MorphoSys Gets Additional License Agreements for Felzartamab, TJ210
14.06.MorphoSys, Human Immunology Enter Into Equity Participation, License Agreements for Fel..
14.06.MorphoSys and HIBio Enter Into Equity Participation and License Agreements for Felzarta..
14.06.MorphoSys and HIBio Enter Into Equity Participation and License Agreements for Felzarta..
14.06.MorphoSys and Human Immunology Biosciences Enter into Equity Participation and License ..
14.06.Global markets live: Oracle, Coty, Ferrari, Pfizer, Amazon...
14.06.Pfizer : lance des essais cliniques avec MorphoSys et Incyte
14.06.Les ours sont lâchés
14.06.EN DIRECT DES MARCHES : TotalEnergies, Atos, Air France-KLM, Techn..
14.06.Pfizer Collaborates with MorphoSys, Incyte to Study Immunotherapeutic Combination in Ly..
13.06.Pfizer, MorphoSys, Incyte Team Up to Study Drug Combination to Treat Lymphoma
13.06.Morphosys : Pfizer, MorphoSys and Incyte Enter into Clinical Trial Collaboration for Monju..
13.06.Pfizer, MorphoSys and Incyte Enter into Clinical Trial Collaboration for Monjuvi® (tafa..
10.06.European ADRs Tumble in Friday Trading
10.06.Morphosys : Presents Multiple Analyses of the MANIFEST Phase 2 Trial Investigating the Pot..
10.06.MorphoSys Presents Multiple Analyses of the MANIFEST Phase 2 Trial Investigating the Po..
10.06.MorphoSys Presents Multiple Analyses of the MANIFEST Phase 2 Trial Investigating the Po..
08.06.European ADRs Move Lower in Wednesday Trading
26.05.European ADRs Move Higher in Thursday Trading
20.05.European ADRs Move Sharply Higher in Friday Trading
19.05.MorphoSys AG Reports Outcome of Annual General Meeting 2022
18.05.MorphoSys AG Reports Outcome of Annual General Meeting 2022
18.05.MorphoSys AG Announces Supervisory Board Changes
16.05.Bolsa de Madrid: Aterrizaje brusco en China
16.05.Atterrissage brutal en Chine
16.05.Avis d'analystes du jour : Michelin, Valeo, Ahold, SMA Solar, S..
13.05.European ADRs Move Higher in Friday Trading
12.05.MorphoSys to Present New Data on Pelabresib and Monjuvi® (tafasitamab-cxix) at the 2022..
12.05.MorphoSys to Present New Data on Pelabresib and Monjuvi® (tafasitamab-cxix) at the 2022..
06.05.European ADRs Move Lower in Friday Trading
05.05.MorphoSys AG Reports Earnings Results for the First Quarter Ended March 31, 2022
05.05.Transcript : MorphoSys AG, Q1 2022 Earnings Call, May 05, 2022
04.05.MorphoSys AG Reports First Quarter 2022 Financial Results
04.05.MorphoSys AG Reports First Quarter 2022 Financial Results
04.05.Morphosys triples Q1 loss as new subsidiary ramps up costs
04.05.MorphoSys AG Reiterates Monjuvi U.S. Net Product Sales Guidance for the Year 2022
29.04.European ADRs Nudge Higher in Friday Trading
29.04.Morphosys : Invitation to MorphoSys' First Quarter 2022 Financial Results Conference Call ..
28.04.Morphosys : Invitation to MorphoSys' First Quarter 2022 Financial Results Conference Call ..
28.04.Invitation to MorphoSys' First Quarter 2022 Financial Results Conference Call on May 5,..
26.04.European ADRs Tumble in Tuesday Trading
20.04.Morphosys : Notification of managers`transactions according to article 19 MAR - Form 6-K
20.04.Morphosys Ag : Notification and public disclosure of transactions by persons
08.04.European ADRs Move Higher in Friday Trading
04.04.European ADRs Nudge Higher in Monday Trading
31.03.European ADRs Move Lower in Thursday Trading
30.03.European ADRs Move Higher in Wednesday Trading
Anstehende Termine für MORPHOSYS AG